Abstract:Pathogenic variants in the Leucine-rich repeat kinase 2 (LRRK2) gene are a primary monogenic cause of Parkinson’s disease (PD). However, the likelihood of developing PD with inherited LRRK2 pathogenic variants differs (a phenomenon known as “reduced penetrance”), with factors including age and geographic region, highlighting a potential role for lifestyle and environmental factors in disease onset. To investigate this, household dust samples from four different groups of individuals were analyzed using metabolomics/exposomics and metagenomics approaches: PD+/LRRK2+ (PD patients with pathogenic LRRK2 variants; n=11), PD-/LRRK2+ (individuals with pathogenic LRRK2 variants but without PD diagnosis; n=8), iPD (PD of unknown cause; n=11), and a matched, healthy control group (n=11). The dust was complemented with metabolomics and lipidomics of matched serum samples, where available. A total of 1,003 chemicals and 163 metagenomic operational taxonomic units (mOTUs) were identified in the dust samples, of which ninety chemicals and ten mOTUs were statistically significant. Reduced levels of 2-benzothiazolesulfonic acid (BThSO3) were found in the PD-/LRRK2+ group compared to the PD+/LRRK2+. A negative and statistically significant association was observed between BThSO3 and Pseudomonas spp. (detected via metagenomics), which are known for degrading benzothiazoles. Among the significant chemicals tentatively identified in dust, two are hazardous chemical replacements: Bisphenol S (BPS), and perfluorobutane sulfonic acid (PFBuS). Furthermore, various lipids were found altered in serum including different lysophosphatidylethanolamines (LPEs), and lysophosphatidylcholines (LPCs), some with higher levels in the PD+/LRRK2+ group compared to the control group. A cellular study on isogenic neurons generated from a PD+/LRRK2+ patient demonstrated that BPS negatively impacts mitochondrial function, which is implicated in PD pathogenesis. This pilot study demonstrates how non-target metabolomics/exposomics analysis of indoor dust samples complemented with metagenomics can prioritize relevant chemicals that may be potential modifiers of LRRK2 penetrance.

What problem does this paper attempt to address?

The problem this paper attempts to address is exploring how environmental factors influence the likelihood of individuals carrying *Leucine-rich repeat kinase 2* (LRRK2) pathological variants developing Parkinson's disease (PD). Specifically, the study seeks to identify environmental modifiers that may affect the penetrance of LRRK2-related Parkinson's disease by analyzing metabolomics/exposomics and metagenomics data from household dust. The study subjects include four different groups: patients with Parkinson's disease carrying LRRK2 pathological variants (PD+/LRRK2+), individuals carrying LRRK2 pathological variants but not diagnosed with Parkinson's disease (PD-/LRRK2+), idiopathic Parkinson's disease patients (iPD), and matched healthy controls. Through these analyses, the researchers aim to identify chemicals and microbial communities associated with LRRK2 penetrance, thereby gaining a better understanding of the role of environmental factors in the pathogenesis of Parkinson's disease.

Exploring Environmental Modifiers of LRRK2-Associated Parkinson’s Disease Penetrance through Exposomics and Metagenomics of Household Dust